Defibrillation vs. Cardioversion
Both are forms of electric countershock therapy that deliver energy across the myocardium to terminate an arrhythmia, but they differ in synchronization, energy, and indication.
Defibrillation
What it is: An unsynchronized high-energy shock delivered as soon as the defibrillator is charged, without regard to the cardiac cycle.
Indication: Pulseless, life-threatening shockable rhythms - ventricular fibrillation (VF) and pulseless ventricular tachycardia (VT). The patient has no pulse, so there is no risk of shocking on a T wave and inducing VF (the reason synchronization matters for cardioversion doesn't apply here).
Technique (Roberts and Hedges' Clinical Procedures in Emergency Medicine):
- Confirm unresponsiveness, absent pulse (<10 sec check), call for help/code cart.
- Apply pads: sternal electrode below the right clavicle, apical electrode in the midaxillary line at the 5th-6th intercostal space.
- Ensure "SYNC" is off.
- Select energy - biphasic: 200 J default first shock; monophasic: 360 J.
- Charge, confirm "I'm clear, you're clear, everybody's clear," then shock.
- Resume CPR immediately for 2 minutes/5 cycles before reassessing rhythm.
Conductive gel/saline pads or self-adhesive pads reduce transthoracic (chest wall) impedance and improve current delivery - Roberts and Hedges' Clinical Procedures in Emergency Medicine, p. 314-315.
Per Braunwald's Heart Disease: "When VF or VT that is pulseless and/or accompanied by loss of consciousness is recognized...defibrillation should be carried out immediately. An initial shock of 120 to 200 J by biphasic devices...should be delivered," with subsequent shocks repeated between cycles of CPR and epinephrine - Braunwald's Heart Disease, p. 669.
Cardioversion
What it is: A synchronized shock, timed by the defibrillator to fire on the R wave, avoiding delivery during the vulnerable T-wave period (which could induce VF).
Indication: Unstable tachyarrhythmias with a pulse - unstable atrial fibrillation/flutter, SVT, and monomorphic VT with a pulse. Sedation is advisable since the shock is painful in an awake patient.
Key technical point: The "SYNC" button must be pressed before each shock - most monitors default back to unsynchronized mode after a shock is delivered, so if a repeat shock is needed, SYNC must be re-engaged each time (a common pitfall).
Typical energy levels (device- and rhythm-dependent):
- Atrial fibrillation: often started around 120-200 J biphasic (updated 2025 AHA guidance favors starting at 200 J - see below)
- Atrial flutter/SVT: lower energies, e.g. 50-100 J
- Monomorphic VT with pulse: 100 J biphasic, escalating if unsuccessful
If the rhythm cannot be reliably synchronized (e.g., polymorphic VT) or the patient is pulseless, treat as VF and defibrillate (unsynchronized) without delay - do not waste time trying to sync.
Side-by-side comparison
| Feature | Defibrillation | Synchronized Cardioversion |
|---|
| Timing | Immediate, unsynced | Synced to R wave |
| Patient state | Pulseless (VF/pulseless VT) | Has a pulse, hemodynamically unstable |
| Typical starting energy | 120-200 J biphasic (360 J monophasic) | Lower, e.g. 50-100 J (AF/flutter now often started higher, see update below) |
| Sedation | Not applicable (unconscious) | Usually given if patient is awake |
| Risk if used on wrong rhythm | N/A | Can induce VF if delivered on T wave (hence sync required) |
Recent evidence update (2025 AHA ACLS Guidelines)
The newly published 2025 American Heart Association Guidelines for CPR and Emergency Cardiovascular Care (Circulation, PMID 41122884) revised cardioversion energy recommendations: for unstable atrial fibrillation/flutter, the guidelines now recommend a higher initial energy of 200 J or more (rather than the older 120 J starting point), because lower initial shocks were associated with lower conversion success and higher risk of rhythm degeneration. They also introduced the concept of "persistent VF" (VF/pulseless VT continuing after 3+ defibrillation attempts), distinguishing "refractory" (never terminates) from "recurrent" (terminates then recurs) VF, with cautious use of dual sequential external defibrillation remaining only a Class IIb recommendation.
Supporting recent systematic reviews/meta-analyses if you want to go deeper:
- Network meta-analysis of electrical vs. pharmacological cardioversion for AF/flutter (Cochrane, PMID 38828867)
- Meta-analysis on techniques improving electrical cardioversion success in AF (Europace, PMID 36503970)
- Systematic review of defibrillation strategies for refractory VF (Am J Emerg Med, PMID 39127020)
- Meta-analysis on active chest compression during external cardioversion of AF (2025, PMID 40167272)
These are consistent with, and update details on top of, the textbook material above - worth flagging since the AHA guideline (2025) changes the previously taught 120 J starting energy for AF cardioversion to 200 J.
Would you like me to go deeper into any specific area - e.g., pediatric defibrillation dosing, ICD/pacemaker considerations during cardioversion, drug-assisted (pharmacological) cardioversion, or the physiology of why VF terminates with a shock?